Disseminated Tumor Cells: Is a Clinically Useful Surrogate Marker at Hand?
Disseminated Tumor Cells: Is a Clinically Useful Surrogate Marker at Hand?
David Portnoy, MD
20080928
2008 Oct 28
Disseminated Tumor Cells: Is a Clinically Useful Surrogate Marker at Hand?
2008 Oct 28, David Portnoy, MD
CTC count may become the much-needed surrogate to assess tumor burden and treatment response in prostate and other cancers.
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
